Potent and selective inhibition of histone deacetylase 6 (HDAC6) does not require a surface-binding motif.
J Med Chem
; 56(4): 1772-6, 2013 Feb 28.
Article
in En
| MEDLINE
| ID: mdl-23368884
Hydroxamic acids were designed, synthesized, and evaluated for their ability to selectively inhibit human histone deacetylase 6 (HDAC6). Several inhibitors, including compound 14 (BRD9757), exhibited excellent potency and selectivity despite the absence of a surface-binding motif. The binding of these highly efficient ligands for HDAC6 is rationalized via structure-activity relationships. These results demonstrate that high selectivity and potent inhibition of HDAC6 can be achieved through careful choice of linker element only.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Histone Deacetylase Inhibitors
/
Histone Deacetylases
/
Hydroxamic Acids
Limits:
Humans
Language:
En
Journal:
J Med Chem
Journal subject:
QUIMICA
Year:
2013
Document type:
Article
Affiliation country:
United States
Country of publication:
United States